--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 11, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Intel
INTC
Alibaba
BABA
Tesla
TSLA
Disney
DIS
Amazon
AMZN
US Stock MarketDetailed Quotes
MLYS Mineralys Therapeutics
- 12.650
- +0.130+1.04%
Trading Dec 31 09:56 ET
629.57MMarket Cap-4.11P/E (TTM)
12.665High12.550Low2.23KVolume12.550Open12.520Pre Close28.11KTurnover0.01%Turnover RatioLossP/E (Static)49.77MShares16.90552wk High2.66P/B342.23MFloat Cap7.95052wk Low--Dividend TTM27.05MShs Float21.980Historical High--Div YieldTTM0.92%Amplitude5.850Historical Low12.616Avg Price1Lot Size
Mineralys Therapeutics Key Stats
Mineralys Therapeutics Q3 2024 Earnings Date
Currency：USDNov 11, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| EPS | -0.82 | -1.13 | -0.31 |
| Miss Est. | -44.74% | -98.25% | -36.99% |
| Net Income | -- | -56.34M | -- |
-147.55% |
Analyst Rating
Nov 30, 2024
Mineralys Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Mineralys Therapeutics Earnings Reports
Read more
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data